Vanda Pharmaceuticals Market Cap

Vanda Pharmaceuticals has a market cap or net worth of $513.06 million as of March 9, 2026. Its market cap has increased by 95.97% in one year.

Market Cap

513.06M

Enterprise Value

261.83M

1-Year Change

95.97%

Ranking

#3023

Market Cap Chart

Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $513.06M, an increase of 144.90%. That is a compound annual growth rate of 4.60%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	466.40M	-10.51%
Dec 31, 2025	521.20M	86.61%
Dec 31, 2024	279.30M	15.03%
Dec 29, 2023	242.80M	-41.94%
Dec 30, 2022	418.20M	-52.16%
Dec 31, 2021	874.10M	21.64%
Dec 31, 2020	718.60M	-17.90%
Dec 31, 2019	875.30M	-36.13%
Dec 31, 2018	1.37B	100.69%
Dec 29, 2017	682.90M	-2.57%
Dec 30, 2016	700.90M	75.84%
Dec 31, 2015	398.60M	-17.90%
Dec 31, 2014	485.50M	17.87%
Dec 31, 2013	411.90M	294.54%
Dec 31, 2012	104.40M	-21.97%
Dec 30, 2011	133.80M	-49.57%
Dec 31, 2010	265.30M	-13.30%
Dec 31, 2009	306.00M	2,200.75%
Dec 31, 2008	13.30M	-92.75%
Dec 31, 2007	183.40M	-66.04%
Dec 29, 2006	540.00M	157.76%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eupraxia Pharmaceuticals	481.69M
Rocket Pharmaceuticals	478.79M
Lyell Immunopharma	477.14M
Atea Pharmaceuticals	469.27M
Kyverna Therapeutics	462.75M
Altimmune	460.45M
Century Therapeutics	459.90M
Entrada Therapeutics	452.88M

Market Cap Rankings